Reviewer's report
Title:C-reactive protein level at two weeks following initiation of infliximab
induction therapy predicts outcomes in patients with ulcerative colitis: A three
year follow-up study.
Version:4Date:23 May 2015
Reviewer: Konstantinos Karmiris
Reviewer's report:
The authors have adequately answered my comments and I have no further
issues to address.
Level of interest: An article of importance in its field
Quality of written English: Needs some language corrections before being
published
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
I declare that I have no competing interests
Reviewer's report
Title:C-reactive protein level at two weeks following initiation of infliximab
induction therapy predicts outcomes in patients with ulcerative colitis: A three
year follow-up study.
Version:4Date:23 May 2015
Reviewer: Konstantinos Karmiris
Reviewer's report:
The authors have adequately answered my comments and I have no further
issues to address.
Level of interest: An article of importance in its field
Quality of written English: Needs some language corrections before being
published
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
I declare that I have no competing interests
Please review this paper.
user
Reviewer's report
Title:C-reactive protein level at two weeks following initiation of infliximab
induction therapy predicts outcomes in patients with ulcerative colitis: A three
year follow-up study.
Version:4Date:23 May 2015
Reviewer: Konstantinos Karmiris
Reviewer's report:
The authors have adequately answered my comments and I have no further
issues to address.
Level of interest: An article of importance in its field
Quality of written English: Needs some language corrections before being
published
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
I declare that I have no competing interests
assistant